These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6288160)

  • 41. [Prevalence of antibodies against hepatitis A in school children].
    Riedemann S; Ibarra H; Reinhardt G; Frösner G; Safary A
    Rev Med Chil; 1998 Oct; 126(10):1161-4. PubMed ID: 10030086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of virus A exposure and viral hepatitis A in India.
    Gandi BM; Joshi YK; Tandon BN
    Lancet; 1981 Aug; 2(8242):374. PubMed ID: 6115152
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatitis A antibodies in two socioeconomically distinct populations of São Paulo, Brazil.
    Pannuti CS; de Mendonça JS; Carvalho MJ; Oselka GW; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1985; 27(3):162-4. PubMed ID: 3006212
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sero-epidemiological characterization of a hepatitis A epidemic associated with a child day care center for a Kuna Indian population in San Blas].
    Betts C; Jaramillo A
    Rev Med Panama; 1984 Jan; 9(1):26-34. PubMed ID: 6322243
    [No Abstract]   [Full Text] [Related]  

  • 45. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan.
    Fujisawa T; Kumagai T; Akamatsu T; Kiyosawa K; Matsunaga Y
    Am J Gastroenterol; 1999 Aug; 94(8):2094-9. PubMed ID: 10445533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody to hepatitis A virus in Liberians.
    Willcox M; Brohult J; Olsson I; Bengtsson E
    Trans R Soc Trop Med Hyg; 1980; 74(5):690. PubMed ID: 6259782
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-hepatitis-A antibody in Spain.
    Vargas V; Esteban R; Pedreira JD; Viladoms J; Hernandez JM; Guardia J
    Lancet; 1978 Sep; 2(8089):583. PubMed ID: 79957
    [No Abstract]   [Full Text] [Related]  

  • 48. [Seroprevalence of hepatitis A antibodies in patients with chronic hepatitis].
    Bañares R; Bory F; Costa J; Dal-Ré R; González A; Navasa M; Planas R; Sansó A; Vargas V
    Gastroenterol Hepatol; 1996 Mar; 19(3):183. PubMed ID: 8991665
    [No Abstract]   [Full Text] [Related]  

  • 49. Seroprevalence of hepatitis A in children--implications for hepatitis A vaccine.
    Mittal SK; Rastogi A; Rastogi A; Kumar N; Talukdar B; Kar P
    Trop Gastroenterol; 1998; 19(3):120-1. PubMed ID: 9828714
    [No Abstract]   [Full Text] [Related]  

  • 50. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibodies to hepatitis A and B in healthy children, mentally retarded children in institutions, and in employees of a children's hospital].
    Bosch C; Frösner GG; Rotthauwe HW
    Klin Padiatr; 1982; 194(6):393-6. PubMed ID: 6296529
    [No Abstract]   [Full Text] [Related]  

  • 52. HAAb titres in hepatitis A.
    Vargas V; Ruiz J; Pedreira JD; Esteban R; Guardia J; Bacardi R; Hernandez JM
    Lancet; 1979 Mar; 1(8116):610-1. PubMed ID: 85195
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance of the level of specific antibodies in the development of the icteric and inapparent forms of viral hepatitis A].
    Katkov AI
    Voen Med Zh; 1987 Apr; (4):32. PubMed ID: 3037788
    [No Abstract]   [Full Text] [Related]  

  • 54. [Patterns of the epidemic process in viral hepatitis A and B in territories with different morbidity levels. I. Hepatitis A].
    Kompaniets AA; Doroshenko NV; Stakhanova VM; Dardik FG; Reĭnaru IK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):70-4. PubMed ID: 6331030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemic of viral hepatitis in a mountain community of western Sicily].
    Intonazzo V; La Rosa G; Lanza A; Famà B; Vazzana G; Romano N; Oliveri R
    Boll Ist Sieroter Milan; 1982 May; 61(2):144-50. PubMed ID: 6289849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outbreak of hepatitis A in a day care center in Finland.
    Pohjanpelto P; Pönkä A
    Scand J Infect Dis; 1985; 17(3):331-2. PubMed ID: 2997910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Viral hepatitis A: specific immunologic aspects before and after exposure to risk].
    Laverdant C; Hainaut J; Dutertre J
    Bull Acad Natl Med; 1983 Jun; 167(6):619-26. PubMed ID: 6318924
    [No Abstract]   [Full Text] [Related]  

  • 58. New methods for the serodiagnosis of hepatitis A.
    Feinstone SM; Purcell RH
    Gastroenterology; 1980 May; 78(5 Pt 1):1092-4. PubMed ID: 6247236
    [No Abstract]   [Full Text] [Related]  

  • 59. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Recommendations for the use of the hepatitis A vaccine in day care centers. Committee on Vaccines of the Spanish Pediatric Society and Spanish Association for the Study of the Liver].
    Gastroenterol Hepatol; 1998; 21(7):346-51. PubMed ID: 9808900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.